Brief: Titan Pharmaceuticals Announces Reverse Stock Split And Ratio
28/12/2023 21:40
Dec 28 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT AND
RATIO
* TITAN PHARMACEUTICALS INC - HAS APPROVED A 1-FOR-20
REVERSE
STOCK SPLIT OF COMPANY'S COMMON STOCK
* TITAN PHARMACEUTICALS: SHARES WILL BEGIN TRADING ON
SPLIT-ADJUSTED BASIS ON NASDAQ FOLLOWING FILING OF AMENDMENT,
INTENDED GO EFFECTIVE ON JAN 9, 2024
Source text for Eikon: ID:nGNX1kljzZ
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.